(Q43034526)

12 November 2017

Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines (English)

1 reference

12 November 2017

1 reference

1 reference

1

1 reference

12 November 2017

3

1 reference

12 November 2017

5

Michael M C Lai

1 reference

12 November 2017

Vicky M H Sung

2

1 reference

PubMed ID

17175001

12 November 2017

Minyi Liu

series ordinal

4

1 reference

PubMed ID

17175001

12 November 2017

language of work or name

English

0 references

publication date

18 December 2006

1 reference

12 November 2017

13

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

12 November 2017

361

1 reference

12 November 2017

1

1 reference

12 November 2017

161-173

1 reference

Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liabilit

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Continuous release of hepatitis C virus (HCV) by peripheral blood mononuclear cells and B-lymphoblastoid cell-line cultures derived from HCV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Immunopathology of hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

CD81 is an entry coreceptor for hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Detection of extrahepatic hepatitis C virus replication by a novel, highly sensitive, single-tube nested polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

The role of immune responses in the pathogenesis of hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Analysis of successful immune responses in persons infected with hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

CD8+ T cell depletion amplifies hepatitis C virus replication in peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Hepatitis C virus expression suppresses interferon signaling by degrading STAT1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Complete replication of hepatitis C virus in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Regulation of PKR and IRF-1 during hepatitis C virus RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Characterization of cell lines carrying self-replicating hepatitis C virus RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Hepatitis C virus-specific T lymphocyte responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Further checkpoints in Th1 development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Genetic analysis of the hepatitis C virus (HCV) genome from HCV-infected human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Robust hepatitis C virus infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.11.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.11.009

1 reference

12 November 2017

1 reference

PubMed ID

17175001